Shiftwork and Prostate-Specific Antigen in the National Health and Nutrition Examination Survey

被引:60
|
作者
Flynn-Evans, Erin E. [1 ,2 ]
Mucci, Lorelei [3 ]
Stevens, Richard G. [4 ]
Lockley, Steven W. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Div Sleep Med, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA 02114 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[4] Univ Connecticut, Ctr Hlth, Dept Community Med, Farmington, CT USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2013年 / 105卷 / 17期
关键词
CANCER INCIDENCE; SLEEP DURATION; BREAST-CANCER; RISK; MELATONIN; COHORT; WORK; OCCUPATION; MORTALITY; INDUSTRY;
D O I
10.1093/jnci/djt169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Shiftwork has been implicated as a risk factor for prostate cancer. Results from prior studies have been mixed but generally support an association between circadian disruption and prostate cancer. Our aim was to investigate the relationship between shiftwork and prostate-specific antigen (PSA) test obtained as part of the National Health and Nutrition Examination Survey (NHANES) study. Methods We combined three NHANES surveys (2005-2010) to obtain current work schedule among employed men aged 40 to 65 years with no prior history of cancer (except nonmelanoma skin cancer). Men who reported working regular night shifts or rotating shifts were considered shiftworkers. We obtained the total and percentage free PSA test results for these men and dichotomized total PSA into less than 4.0 ng/mL or 4.0 ng/mL or greater and total PSA of 4.0 ng/mL or greater combined with percentage free PSA less than or equal to 25%. Using multivariable logistic regression models, we compared PSA level among current shiftworkers and nonshiftworkers. All statistical tests were two-sided. Results We found a statistically significant, age-adjusted association between current shiftwork and elevated PSA at the 4.0 ng/mL or greater level (odds ratio = 2.48, 95% confidence interval [CI] = 1.08 to 5.70; P = .03). The confounder-adjusted odds ratio was 2.62 (95% CI = 1.16 to 5.95; P = .02). The confounder-adjusted odds ratio for those with total PSA of 4.0 ng/mL or greater and free PSA less than or equal to 25% was 3.13 (95% CI = 1.38 to 7.09; P = .01). Conclusions We observed a strong positive association with shiftwork and elevated PSA level. Our data support the notion that sleep or circadian disruption is associated with elevated PSA, indicating that shiftworking men likely have an increased risk of developing prostate cancer.
引用
收藏
页码:1292 / 1297
页数:6
相关论文
共 50 条
  • [21] Health Characteristics and Sedentary Behavior Impact on Prostate-Specific Antigen Levels in a National US Sample
    Loprinzi, Paul D.
    Kohli, Manish
    JOURNAL OF PHYSICAL ACTIVITY & HEALTH, 2014, 11 (08) : 1587 - 1592
  • [22] Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices
    Goldenberg, Mitchell Geoffrey
    Skeldon, Sean C.
    Nayan, Madhur
    Suppiah, Yegappan
    Chow, Linda
    Fryml, Elise
    Greenberg, David
    Singal, Rajiv K.
    Goldenberg, S. Larry
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (12): : 396 - +
  • [23] A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal Disparities
    Cussenot, Olivier
    Taille, Yoann
    Portal, Jean-Jacques
    Cancel-Tassin, Geraldine
    Roupret, Morgan
    de la Taille, Alexandre
    Ploussard, Guillaume
    Mathieu, Romain
    Hamdy, Freddie C.
    Vicaut, Eric
    EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 978 - 981
  • [24] Prostate-Specific Antigen Screening in Prostate Cancer: Perspectives on the Evidence
    Wilt, Timothy J.
    Scardino, Peter T.
    Carlsson, Sigrid V.
    Basch, Ethan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (03):
  • [25] Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher T.
    CLINICAL BIOCHEMISTRY, 2015, 48 (18) : 1230 - 1234
  • [26] Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: A survey of US transplantation centers
    Gin, Greg E.
    Pereira, Jorge F.
    Weinberg, Alan D.
    Mehrazin, Reza
    Lerner, Susan M.
    Sfakianos, John P.
    Phillips, Courtney K.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (02) : 57.e9 - 57.e13
  • [27] Association between smoking and neutrophil to lymphocyte ratio among prostate cancer survivors: the National Health and Nutrition Examination Survey
    Kao, Yu-Hsiang
    Lin, Wei-Ting
    Thomas, Casey L.
    Lin, Hui-Yi
    Tseng, Tung-Sung
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S346 - +
  • [28] The Dilemma of Prostate-Specific Antigen Testing
    Leach, Robin
    Thompson, Ian M.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (11) : 835 - 836
  • [29] Prostate-specific antigen screening: pro
    Loeb, Stacy
    Catalona, William J.
    CURRENT OPINION IN UROLOGY, 2010, 20 (03) : 185 - 188
  • [30] Is the era of prostate-specific antigen over?
    Djavan, Bob
    Rocco, Bernardo
    Stangelberger, Anton
    De Cobelli, Ottavio
    Marberger, Michael
    BJU INTERNATIONAL, 2007, 100 : 8 - 10